• 1
    Jennette JC, Falk RJ. Overview of the nomenclature and diagnostic categorization of vasculitis [review]. Wien Klin Wochenschr 2000; 112: 6505.
  • 2
    Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Drosos AA, Moutsopoulos HM. Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol 1997; 36: 105966.
  • 3
    Jennette JC, Wilkman AS, Falk RJ. Diagnostic predictive value of ANCA serology. Kidney Int 1998; 53: 7968.
  • 4
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al, for the EC/BCR project for ANCA assay standardization. The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Kidney Int 1998; 53: 74353.
  • 5
    Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangiitis and classic polyarteritis nodosa. Arch Dis Child 2001; 85: 42730.
  • 6
    Seo P, Stone J. The antineutrophil cytoplasmic antibody- associated vasculitides. Am J Med 2004; 117: 3950.
  • 7
    Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 1996; 35: 95864.
  • 8
    Schrader ML, Hochman JS, Bulkley BH. The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 1985; 109: 13539.
  • 9
    Forstot JZ, Overlie PA, Neufeld GK, Harmon GE, Forstot SL. Cardiac complications of Wegener's granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum 1980; 10: 14854.
  • 10
    Lanham JG, Cooke S, Davies J, Hughes GR. Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J 1985; 61: 3414.
  • 11
    Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 2005; 14: 15.
  • 12
    Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 42130.
  • 13
    Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener's granulomatosis and the heart. Br Heart J 1994; 71: 826.
  • 14
    Morelli S, Gurgo Di Castelmenardo AM, Conti F, Sgreccia A, Alessandri C, Bernardo ML, et al. Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int 2000; 19: 20912.
  • 15
    Smedema JP, van Passen P, van Kroonenburgh MJ, Snoep G, Crijns HJ, Tervaert JW. Cardiac involvement of Churg-Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 2004; 22(6 Suppl 36 ): S758.
  • 16
    Sorensen SF, Slot O, Tvede N, Petersen J. A prospective study of vasculitis patients collected in a five-year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 2000; 59: 47882.
  • 17
    Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Rheum 2004; 51: 929.
  • 18
    Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 6718.
  • 19
    Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, et al, for the Vasculitis Clinical Research Consortium. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis: report from OMERACT 7. J Rheumatol 2005; 32: 248895.
  • 20
    Fischer SE, Wickline SA, Lorenz CH. Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med 1999; 42: 36170.
  • 21
    Stuber M, Botnar RM, Danias PG, Kissinger KV, Manning WJ. Submillimeter three-dimensional coronary MR angiography with real-time navigator correction: comparison of navigator locations. Radiology 1999; 212: 57987.
  • 22
    Botnar RM, Stuber M, Danias PG, Kissinger KV, Manning WJ. Improved coronary artery definition with T2-weighted, free breathing three-dimensional coronary MRA. Circulation 1999; 99: 313948.
  • 23
    Stuber M, Botnar RM, Danias PG, Sodickson DK, Kissinger KV, Van Cauteren M, et al. Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol 1999; 34: 52431.
  • 24
    Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of the presence, location and transmural extent of healed Q-wave and non–Q-wave myocardial infarction. Lancet 2001; 357: 218.
  • 25
    Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol 2004; 93: 65761.
  • 26
    Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 19922002.
  • 27
    Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, et al. Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of the coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004; 43: 64952.
  • 28
    Befeler B, Aranda JM, Embi A, Mullin FL, El-Sherif N, Lazzara R. Coronary artery aneurysms: study of their etiology, clinical course and effect on left ventricular function and prognosis. Am J Med 1977; 62: 597607.
  • 29
    Mavrogeni SI, Manginas A, Papadakis E, Foussas S, Douskou M, Baras P, et al. Correlation between magnetic resonance angiography (MRA) and quantitative coronary angiography (QCA) in ectatic coronary vessels. J Cardiovasc Magn Reson 2004; 6: 1723.
  • 30
    Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: 14857.
  • 31
    Guillevin L, Dorner T. Vasculitis: mechanisms involved and clinical manifestations [review]. Arthritis Res Ther 2007; 9 Suppl 2: S9.
  • 32
    Mandell B, Hoffman G. Rheumatic diseases and the cardiovascular system. In: ZipesD, LibbyP, BonowR, BraunwaldE, editors. Braunwald's heart disease. 7th ed. Philadelphia: Saunders; 2005. p. 210116.
  • 33
    Li JJ, Li Z, Li J. Is any link between inflammation and coronary ectasia? Med Hypotheses 2007; 69: 67883.
  • 34
    Papadakis M, Manginas A, Cotileas P, Demopoulos V, Voudris V, Pavlides G, et al. Documentation of slow coronary flow by TIMI frame count in patients with coronary artery ectasia. Am J Cardiol 2001; 88: 10302.
  • 35
    Al-Harthi SS, Nouh MS, Arafa M, Al-Nozha M. Aneurysmal dilatation of the coronary arteries: diagnostic patterns and clinical significance. Int J Cardiol 1991; 30: 1914.
  • 36
    Mavrogeni S, Tsirogianni AK, Gialafos EJ, Manoussakis MN. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg-Strauss syndrome [letter]. Int J Cardiol 2009; 131: 545.
  • 37
    Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV. Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease. Int J Cardiol 2008. E-pub ahead of print.
  • 38
    Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113: 273343.